Meropenem Iv Infusion 500 mg, 1 g, 2 g in vials Suppliers & Bulk Manufacturers
Available Forms: Powder for Reconstitution
Available Strengths: 500 mg, 1 g, 2 g in vials
Reference Brands: Merrem (US & EU), Merosan (india)
Category: Antibiotics
Meropenem IV inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid, potent bactericidal effect, excellent tissue penetration, and use in critical infections, ensuring reliable, effective treatment in hospital settings.
Product Description:
Meropenem IV infusion is approved in the EU and US for severe bacterial infections including pneumonia, urinary tract infections, and intra-abdominal sepsis. In the EU, brands like Merrem are regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its critical role in combatting resistant bacteria, strict prescribing and monitoring guidelines are enforced. For expert help with regulatory dossiers, compliance, and registration, visit PharmaTradz. We enable seamless market access aligned with European and US standards.
Meropenem Iv Infusion — third party manufacturing & bulk supply
Meropenem Iv Infusion 500 mg, 1 g, 2 g in vials is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Meropenem Iv Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Meropenem Iv Infusion →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Meropenem is used to treat serious bacterial infections such as complicated intra-abdominal infections, meningitis, hospital-acquired pneumonia, and complicated skin and soft tissue infections. It is commonly administered in hospitals for infections caused by susceptible bacteria.
Meropenem is made from the active pharmaceutical ingredient meropenem trihydrate, a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis and stopping the growth of bacteria.
Common trade names include Merrem and Merosan.
The originator brand Merrem was developed and marketed by AstraZeneca. Generic versions including Merosan and other brands are manufactured by various pharmaceutical companies globally.
The generic name is meropenem trihydrate.
Brand names include Merrem and Merosan.
Meropenem injections are manufactured in several countries including the United States, European countries, India, and Latin American regions in pharmaceutical facilities that follow regulatory standards such as US FDA, EMA, and other national authorities.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
